Stock listing

Frankfurt:05Y Vivoryon Therapeutics N.V. Aktie

German listing (Frankfurt) of Vivoryon Therapeutics N.V. · home listing Euronext:VVY

Follow Vivoryon Therapeutics N.V. into a list and get an email when it puts out news.

Share price · FWB:05Y

€0.828 EUR -0.022 (-2.6%)

Close on Oct 30, 2026

Day range
€0.828 – €0.828 EUROct 30, 2026
Market cap
€24.52M EURAt the close on Oct 30, 2026 · price × 29.61M shares outstanding
Vivoryon Therapeutics N.V. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:VVY · Home€0.78 EUR-0.022 (-2.7%)53,572€0.77€0.782€0.758€0.802Close on Nov 2, 2026
LSE:0R3M€0.85 EUR+0.002 (+0.2%)2€0.85€0.85€0.85€0.848Close on Oct 27, 2026
Frankfurt:05Y€0.828 EUR-0.022 (-2.6%)—€0.828€0.828€0.828€0.850Close on Oct 30, 2026
Ticker
Frankfurt:05Y
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Vivoryon Therapeutics (Euronext:VVY) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 5:00 PM ET

    Watch Transcript

Latest news

All Vivoryon Therapeutics N.V. news

Decks

Vivoryon Therapeutics N.V. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
15 in the last 12 months · 29 in all · newest Sep 29, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Aug 6, 2026
Decks
39 decks · latest Sep 29, 2026

Where Vivoryon Therapeutics N.V. is listed

ListingExchangeCountryCurrency
Euronext:VVY · Home listingEuronextNetherlandsEUR
gettex:05YgettexGermanyEUR
Tradegate:05YTradegateGermanyEUR
Lang & Schwarz:A2QJV6Lang & SchwarzGermanyEUR
LSE:0R3MLSEUnited KingdomEUR
Frankfurt:05Y · This pageFrankfurtGermanyEUR
LS Exchange:A2QJV6LS ExchangeGermanyEUR
Aquis:VVYAAquisUnited KingdomEUR
Aquis:VVYAAquisUnited KingdomEUR
Stuttgart:05YStuttgartGermanyEUR
Turquoise:VVYATurquoiseUnited KingdomEUR
Dusseldorf:05YDusseldorfGermanyEUR
Hamburg:05YHamburgGermanyEUR
Munich:05YMunichGermanyEUR
VIE:VVYNViennaAustriaEUR

Log in to ask 6ix AI your own questions about Vivoryon Therapeutics N.V.